# Biocryst Pharmaceuticals Inc: filings

BCRX · Nasdaq · CIK 882796 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcrx.md) · [Financials](/companies/bcrx/financials.md) · [Filings](/companies/bcrx/filings.md) · [Insiders](/companies/bcrx/insiders.md)

## Reports and events: 424 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 757, 8-K 315, SC 13G/A 73, 10-Q 53, 425 51, 3 34, SC 13G 29, S-8 23, CT ORDER 21, 144 20, DEF 14A 19, 10-K 18, DEFA14A 16, 424B2 10, 424B5 10, CORRESP 10, SC 13D/A 10, EFFECT 9, UPLOAD 8, 4/A 7, ARS 6, S-3 5, SCHEDULE 13G/A 5, 8-K/A 4, 3/A 3, PRE 14A 3, S-3/A 3, S-3ASR 3, SC 13D 3, SCHEDULE 13G 3, 10-K/A 2, 424B3 2, DEFM14A 2, POS AM 1, S-4 1, S-4/A 1, SC 13E3/A 1, SEC STAFF LETTER 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:04 ET | [10-Q](/filings/0001628280-26-053300.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053300 |
| 2026-08-05 | 07:02 ET | [8-K](/filings/0001171843-26-005223.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005223 |
| 2026-08-04 | 07:01 ET | [8-K/A](/filings/0001171843-26-005168.md) | 2.05 Exit or disposal costs | 0001171843-26-005168 |
| 2026-06-29 | 07:06 ET | [8-K](/filings/0001171843-26-004333.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-004333 |
| 2026-06-12 | 16:10 ET | [8-K](/filings/0001171843-26-004096.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-004096 |
| 2026-05-06 | 16:06 ET | [10-Q](/filings/0001628280-26-031238.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031238 |
| 2026-05-06 | 07:08 ET | [8-K](/filings/0001171843-26-003052.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003052 |
| 2026-05-04 | 07:06 ET | [8-K](/filings/0001171843-26-002960.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-002960 |
| 2026-04-23 | 16:02 ET | [DEF 14A](/filings/0001628280-26-026822.md) | Proxy statement, period 2026-06-11 | 0001628280-26-026822 |
| 2026-02-26 | 16:03 ET | [10-K](/filings/0001628280-26-012240.md) | Annual report, period 2025-12-31 | 0001628280-26-012240 |
| 2026-02-26 | 07:19 ET | [8-K](/filings/0001171843-26-001119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001119 |
| 2026-01-23 | 16:32 ET | [8-K/A](/filings/0001171843-26-000405.md) | 5.02 Departure or appointment of officers or directors | 0001171843-26-000405 |
| 2026-01-23 | 16:30 ET | [8-K](/filings/0001140361-26-002200.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002200 |
| 2026-01-12 | 16:28 ET | [8-K](/filings/0001171843-26-000213.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-000213 |
| 2026-01-09 | 07:01 ET | [8-K](/filings/0001171843-26-000154.md) | 7.01 Regulation FD disclosure | 0001171843-26-000154 |
| 2025-12-12 | 07:51 ET | [8-K](/filings/0001171843-25-007909.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-007909 |
| 2025-12-11 | 07:25 ET | [8-K](/filings/0001171843-25-007878.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-007878 |
| 2025-12-03 | 08:00 ET | [8-K](/filings/0001140361-25-044110.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-044110 |
| 2025-11-04 | 16:02 ET | [10-Q](/filings/0001628280-25-048785.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048785 |
| 2025-11-03 | 07:13 ET | [8-K](/filings/0001171843-25-006881.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-006881 |
| 2025-10-14 | 07:10 ET | [8-K](/filings/0001140361-25-038031.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-038031 |
| 2025-10-01 | 08:03 ET | [8-K](/filings/0001140361-25-036875.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-036875 |
| 2025-08-11 | 07:10 ET | [8-K](/filings/0001171843-25-005265.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-005265 |
| 2025-08-05 | 16:03 ET | [10-Q](/filings/0001628280-25-037795.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037795 |
| 2025-08-04 | 07:12 ET | [8-K](/filings/0001171843-25-004977.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004977 |
| 2025-07-31 | 07:03 ET | [8-K](/filings/0001171843-25-004869.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004869 |
| 2025-07-07 | 07:04 ET | [8-K](/filings/0001171843-25-004324.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-004324 |
| 2025-06-30 | 07:37 ET | [8-K](/filings/0001140361-25-024089.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-024089 |
| 2025-06-27 | 07:10 ET | [8-K](/filings/0001171843-25-004186.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-004186 |
| 2025-06-25 | 06:57 ET | [8-K](/filings/0001171843-25-004091.md) | 8.01 Other events | 0001171843-25-004091 |
| 2025-06-16 | 16:13 ET | [8-K](/filings/0001171843-25-003910.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-003910 |
| 2025-06-04 | 07:27 ET | [8-K](/filings/0001171843-25-003662.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-003662 |
| 2025-05-14 | 07:16 ET | [8-K](/filings/0001171843-25-003152.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-003152 |
| 2025-05-06 | 16:03 ET | [10-Q](/filings/0001628280-25-022658.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022658 |
| 2025-05-05 | 07:11 ET | [8-K](/filings/0001171843-25-002739.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-002739 |
| 2025-05-01 | 07:14 ET | [8-K](/filings/0001171843-25-002669.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-002669 |
| 2025-04-24 | 16:03 ET | [DEF 14A](/filings/0001628280-25-019659.md) | Proxy statement, period 2025-06-12 | 0001628280-25-019659 |
| 2025-04-10 | 16:02 ET | [8-K](/filings/0001171843-25-002147.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-002147 |
| 2025-03-11 | 06:26 ET | [8-K](/filings/0001171843-25-001383.md) | 8.01 Other events | 0001171843-25-001383 |
| 2025-03-04 | 08:01 ET | [8-K](/filings/0001171843-25-001231.md) | 5.02 Departure or appointment of officers or directors | 0001171843-25-001231 |
| 2025-02-25 | 16:02 ET | [10-K](/filings/0001628280-25-007715.md) | Annual report, period 2024-12-31 | 0001628280-25-007715 |
| 2025-02-24 | 07:06 ET | [8-K](/filings/0001171843-25-001020.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001020 |
| 2025-01-13 | 07:09 ET | [8-K](/filings/0001171843-25-000190.md) | 7.01 Regulation FD disclosure | 0001171843-25-000190 |
| 2025-01-10 | 07:13 ET | [8-K](/filings/0001171843-25-000155.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-000155 |
| 2025-01-08 | 07:20 ET | [8-K](/filings/0001171843-25-000112.md) | 7.01 Regulation FD disclosure | 0001171843-25-000112 |
| 2024-11-05 | 17:19 ET | [10-Q](/filings/0001628280-24-045364.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045364 |
| 2024-11-04 | 07:06 ET | [8-K](/filings/0001171843-24-005975.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005975 |
| 2024-10-02 | 07:06 ET | [8-K](/filings/0001171843-24-005439.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-24-005439 |
| 2024-09-30 | 07:11 ET | [8-K](/filings/0001171843-24-005393.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-24-005393 |
| 2024-08-06 | 16:04 ET | [10-Q](/filings/0001628280-24-035170.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035170 |

Page 1 of 9. [Older](/companies/bcrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.